HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Ji Selected Research

diphenylbutadiene

8/2019Identification of Catechol-Type Diphenylbutadiene as a Tyrosinase-Activated Pro-oxidative Chemosensitizer against Melanoma A375 Cells via Glutathione S-Transferase Inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Ji Research Topics

Disease

108Neoplasms (Cancer)
06/2022 - 01/2002
31Hepatocellular Carcinoma (Hepatoma)
04/2022 - 03/2002
14Neoplasm Metastasis (Metastasis)
01/2022 - 11/2003
13Stomach Neoplasms (Stomach Cancer)
10/2021 - 06/2014
13Adenocarcinoma
01/2021 - 11/2008
8Pancreatic Neoplasms (Pancreatic Cancer)
03/2019 - 02/2006
7Major Depressive Disorder (Major Depressive Disorders)
11/2021 - 03/2013
6Breast Neoplasms (Breast Cancer)
12/2021 - 01/2006
6Carcinogenesis
11/2018 - 12/2003
5Hemorrhage
01/2022 - 10/2015
5Cholangiocarcinoma
12/2020 - 11/2008
5Infections
01/2020 - 01/2011
5Primitive Neuroectodermal Tumors (PNET)
02/2018 - 05/2013
5Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2018 - 05/2013
4Hepatitis B
01/2020 - 01/2011
4Liver Neoplasms (Liver Cancer)
12/2019 - 12/2003
4Hodgkin Disease (Hodgkin's Disease)
04/2012 - 07/2011
4Lymphoma (Lymphomas)
02/2012 - 03/2009
3Inflammation (Inflammations)
07/2022 - 12/2013
3Lung Neoplasms (Lung Cancer)
12/2021 - 10/2009
3Liver Cirrhosis (Hepatic Cirrhosis)
06/2021 - 02/2010
3Necrosis
12/2019 - 06/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2019 - 10/2009
3Fibrosis (Cirrhosis)
01/2019 - 01/2014
3Neoplasms, Cystic, Mucinous, and Serous
12/2017 - 02/2006
3Lymphatic Metastasis
10/2015 - 05/2013
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2015 - 01/2011
2Myocardial Infarction
07/2022 - 09/2021
2Acute Kidney Injury (Acute Renal Failure)
07/2022 - 10/2021
2Fatigue
01/2022 - 11/2016
2Leiomyosarcoma
01/2022 - 09/2011
2Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 01/2020
2Cavernous Hemangioma (Cavernous Angioma)
11/2021 - 01/2021
2Osteosarcoma (Osteogenic Sarcoma)
12/2020 - 09/2013
2Varicose Veins (Varicose Vein)
04/2020 - 01/2020
2Cardiac Arrhythmias (Arrythmia)
01/2020 - 10/2017
2Prostatic Neoplasms (Prostate Cancer)
11/2018 - 09/2013
2Carcinoma (Carcinomatosis)
12/2017 - 11/2003
2Acute Liver Failure (Fulminant Hepatic Failure)
02/2016 - 03/2011

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
22Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2009
14Biological ProductsIBA
08/2022 - 01/2006
11Pharmaceutical PreparationsIBA
01/2022 - 01/2006
10Capsules (Microcapsules)IBA
04/2022 - 01/2002
10DNA (Deoxyribonucleic Acid)IBA
11/2020 - 12/2003
8Messenger RNA (mRNA)IBA
01/2021 - 11/2003
8AntigensIBA
12/2020 - 12/2003
7ParaffinIBA
01/2018 - 06/2002
6MucinsIBA
11/2008 - 02/2006
5MicroRNAs (MicroRNA)IBA
06/2022 - 08/2007
5AntibodiesIBA
07/2021 - 01/2018
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 06/2014
5Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2019 - 03/2013
4RNA (Ribonucleic Acid)IBA
01/2022 - 06/2014
4ChemokinesIBA
07/2019 - 10/2011
4CytokinesIBA
07/2019 - 09/2011
4Capecitabine (Xeloda)FDA Link
06/2018 - 12/2003
4Indicators and Reagents (Reagents)IBA
01/2018 - 03/2002
4SurvivinIBA
10/2016 - 10/2011
3Immune Checkpoint InhibitorsIBA
01/2022 - 10/2021
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2013
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 12/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 10/2010
3Estrogens (Estrogen)FDA Link
05/2020 - 06/2005
3Sorafenib (BAY 43-9006)FDA Link
01/2020 - 01/2018
3Carcinoembryonic AntigenIBA
01/2020 - 06/2015
3Trastuzumab (Herceptin)FDA Link
11/2019 - 06/2016
3CopperIBA
08/2019 - 01/2018
3Keratin-19 (Keratin 19)IBA
04/2019 - 06/2008
3Therapeutic UsesIBA
04/2019 - 01/2017
3Codon (Codons)IBA
09/2018 - 11/2011
3XELOXIBA
06/2018 - 06/2014
3Selenium-Binding ProteinsIBA
01/2018 - 06/2012
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2011 - 06/2008
2NivolumabIBA
01/2022 - 10/2021
2CreatinineIBA
04/2021 - 10/2010
2IronIBA
01/2021 - 10/2015
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020 - 01/2020
2Hepatitis B e AntigensIBA
01/2020 - 01/2020
2Triglycerides (Triacylglycerol)IBA
01/2020 - 09/2015
2Cisplatin (Platino)FDA LinkGeneric
08/2019 - 03/2002
2Glutathione (Reduced Glutathione)IBA
08/2019 - 12/2018
2Keratins (Keratin)IBA
08/2019 - 06/2008
2InterferonsIBA
04/2019 - 10/2011
2Cell-Free Nucleic AcidsIBA
03/2019 - 01/2018
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019 - 12/2010
2Immunoglobulin G (IgG)IBA
01/2019 - 12/2017
2IonophoresIBA
12/2018 - 01/2018
2NucleotidesIBA
01/2018 - 02/2016
2Chromogranin AIBA
01/2018 - 05/2015
2EverolimusFDA Link
11/2017 - 04/2012
2EnzymesIBA
11/2016 - 12/2010

Therapy/Procedure

28Therapeutics
06/2022 - 09/2011
17Drug Therapy (Chemotherapy)
01/2022 - 03/2008
5Hepatectomy
07/2021 - 06/2018
4Precision Medicine
01/2021 - 01/2016
4Radiotherapy
01/2021 - 12/2010
3Immunotherapy
01/2022 - 01/2021
3Liver Transplantation
05/2009 - 06/2005
2Adjuvant Chemotherapy
01/2019 - 06/2014